Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Learn the long-term average annual return for index funds and how it informs portfolio construction, diversification, and risk management.
27,739 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
From a couch-bound gamer to a Big Ten Player of the Year, Yaxel Lendeborg is redefining more than basketball — he’s i...
A high-profile inmate known as the Gilgo Beach serial killer is spending years in isolation, reading crime fiction, a...
Animoca Brands announces a strategic investment in the AVAX token and a partnership with Ava Labs to accelerate Avala...
A new White House mascot, meet ‘coalie,’ anime-style anthropomorphic coal, is shaping how investors view energy polic...
A cross-chain breach targeting the Verus-Ethereum bridge drained more than $11 million, triggering renewed focus on s...
A prominent Hyperliquid holder dumped about $9 million worth of HYPE as the token surged to new highs, underscoring a...
AI-driven analysis explores XRP's possible path to higher prices if Ripple secures a Fed master account. The piece ou...
The United States designated Nobitex, Iran’s largest crypto exchange, along with three other Iranian digital-asset pl...
Dreaming of a destination wedding? This budget-focused guide draws on the Venice-inspired celebrations around Giannin...
As inflation remains stubborn, Bank of America nudges its rate outlook higher, forecasting three quarter-point Fed hi...
Regulated banks can custody crypto and settle tokenized funds, but Basel's capital rules impose a punishing cost that...